Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer
Expanded leadership team positioned to advance the company’s development and commercialization plans NAARDEN, The Netherlands & WALTHAM, Mass. – Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of two key leaders to its management team – Mr. Rob Lauzen as Chief Financial … Continue reading Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer